- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05172882
Efficacy of Transversalis Fascia Plane Block Versus Wound Infiltration in Varicoselectomy Surgery
November 8, 2022 updated by: Erkan Cem ÇELİK, Ataturk University
Comparison of the Efficacy of Transversalis Fascia Plane Block and Wound Infiltration in Varicoselectomy Surgery; Randomised, Controlled Study.
Before surgery, patients will be divided into 2 groups as transversalis fascia plane block will be applied and skin infiltration will be applied.
Post-operative analgesic procedures will be applied to patients receiving general anesthesia.
Postoperative analgesic consumption and pain scores of the patients will be evaluated.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Erzurum, Turkey, 25080
- Erkan Cem ÇELİK
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patients over the age of 18 who will undergo Varicocele operation
- ASA I-II
Exclusion Criteria:
- Patients with allergic reaction to anesthesia and analgesia drugs to be used
- Patients who did not want to voluntarily participate in the study
- Severe systemic disease (kidney, liver, pulmonary, endocrine)
- Substance abuse history
- Chronic pain history
- Psychiatric problems and communication difficulties
- History of hematological problem
- Patients with severe hemodynamic instability due to infection, heavy bleeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Wound Infiltration
Wound infiltration will be applied to the surgical incision site for patients in this group.
Infiltration fluid will contain 20 ml 0.25% bupivakain.
|
Block fluids that were prepared as 20 ml 0.25% bupivacaine before the intervention, will be applied through the upper and lower incision lips on the suprainguinal surgical site.
|
Experimental: Transversalis Fascia Plane Block
Transversalis fascia plane block will be performed on only one periinguinal side for patients in this group.
Block fluid will contain 20 ml 0.25% bupivakain.
|
External, internal oblique, and transversus abdominis muscles will be visualized by the ultrasound device.
After transversalis fascia will be seen, transversalis fascia plane block will be performed.
As a block fluid 20 ml 0.25% bupivacaine will be applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Scores (0 (low)-10 (high))
Time Frame: 1st hour
|
Pain will be assessed by visual analog scale scores
|
1st hour
|
Pain Scores (0 (low)-10 (high))
Time Frame: 2nd hour
|
Pain will be assessed by visual analog scale scores
|
2nd hour
|
Pain Scores (0 (low)-10 (high))
Time Frame: 4th hour
|
Pain will be assessed by visual analog scale scores
|
4th hour
|
Pain Scores (0 (low)-10 (high))
Time Frame: 8th hour
|
Pain will be assessed by visual analog scale scores
|
8th hour
|
Pain Scores (0 (low)-10 (high))
Time Frame: 12th hour
|
Pain will be assessed by visual analog scale scores
|
12th hour
|
Pain Scores (0 (low)-10 (high))
Time Frame: 24th hour
|
Pain will be assessed by visual analog scale scores
|
24th hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rescue analgesic consumption
Time Frame: Any time on postsurgical first 24 hour.
|
Analgesic drug consumption will be assessed
|
Any time on postsurgical first 24 hour.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2021
Primary Completion (Actual)
March 15, 2022
Study Completion (Actual)
April 15, 2022
Study Registration Dates
First Submitted
November 23, 2021
First Submitted That Met QC Criteria
December 10, 2021
First Posted (Actual)
December 29, 2021
Study Record Updates
Last Update Posted (Actual)
November 9, 2022
Last Update Submitted That Met QC Criteria
November 8, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ATATÜRK ÜNİVERSİTESİ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesia
-
Mansoura UniversityNot yet recruiting
-
Southeast University, ChinaRecruiting
-
Medical University of South CarolinaRecruiting
-
Southeast University, ChinaRecruiting
-
Huazhong University of Science and TechnologyRecruiting
-
Mansoura UniversityCompleted
-
University of FloridaMdoloris Medical SystemsCompletedAnalgesiaUnited States
-
Mansoura UniversityCompleted
-
Cessatech A/SCompleted
-
Kalyra Pharmaceuticals, Inc.United States Department of Defense; PRA Health SciencesTerminated
Clinical Trials on Wound site infiltration
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedInguinal Hernia | Post Operative Pain | Erector Spinae Plane BlockTurkey
-
Tanta UniversityCompletedRole of Platelet Rich Plasma in Wound HealingEgypt
-
University Hospital Schleswig-HolsteinActive, not recruitingDigit Tip Wound | Split Skin Donor SiteGermany
-
Tunis UniversityRecruiting
-
Dr Muhammad ArifRecruiting
-
University of California, DavisRecruitingOpioid Use | Post Operative Pain | Nausea and Vomiting, PostoperativeUnited States
-
Seoul National University Bundang HospitalRecruitingPain, PostoperativeKorea, Republic of
-
Derince Training and Research HospitalBursa Yüksek İhtisas Education and Research HospitalCompletedPostoperative PainTurkey
-
ivWatch, LLCCompleted